Intest Res.  2018 Apr;16(2):312-314. 10.5217/ir.2018.16.2.312.

Should Asian inflammatory bowel disease patients need routine thromboprophylaxis?

• Weng MT
• Tung CC
• Wong JM
• Wei SC

• KMID: 2417685
• DOI: http://doi.org/10.5217/ir.2018.16.2.312

Abstract

No abstract available.

MeSH Terms

Asian Continental Ancestry Group*
Humans
Inflammatory Bowel Diseases*

Reference

1. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011; 140:1785–1794. PMID: 21530745.

2. Vegh Z, Kurti Z, Lakatos PL. Epidemiology of inflammatory bowel diseases from west to east. J Dig Dis. 2017; 18:92–98. PMID: 28102560.

3. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103:3167–3182. PMID: 19086963.

4. Burwen DR, Wu C, Cirillo D, et al. Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims. Thromb Res. 2017; 150:78–85. PMID: 28063368.

5. Arshad N, Bjøri E, Hindberg K, Isaksen T, Hansen JB, Braekkan SK. Recurrence and mortality after first venous thromboembolism in a large population-based cohort. J Thromb Haemost. 2017; 15:295–303. PMID: 27943560.

6. Spencer FA, Emery C, Joffe SW, et al. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism: the Worcester VTE study. J Thromb Thrombolysis. 2009; 28:401–409. PMID: 19629642.

7. Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med. 2014; 127:829–839. PMID: 24813864.

8. Cohen A, Chiu KM, Park K, et al. Managing venous thromboembolism in Asia: winds of change in the era of new oral anticoagulants. Thromb Res. 2012; 130:291–301. PMID: 22766512.

9. Huang SS, Liu Y, Jing ZC, Wang XJ, Mao YM. Common genetic risk factors of venous thromboembolism in Western and Asian populations. Genet Mol Res. 2016; 15:15017644. DOI: 10.4238/gmr.15017644. PMID: 26985940.

10. Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011; 60:937–943. PMID: 21339206.

11. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010; 375:657–663. PMID: 20149425.

12. Chung WS, Lin CL, Hsu WH, Kao CH. Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study. Thromb Res. 2015; 135:492–496. PMID: 25596768.

13. Nguyen GC, Bernstein CN, Bitton A, et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology. 2014; 146:835–848. PMID: 24462530.

14. Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol. 2006; 28:111–116. PMID: 16630215.

15. DeBoer MD, Gurka MJ. Clinical utility of metabolic syndrome severity scores: considerations for practitioners. Diabetes Metab Syndr Obes. 2017; 10:65–72. PMID: 28255250.

16. Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol. 2014; 20:13863–13878. PMID: 25320522.

17. Song HK, Lee KM, Jung SA, et al. Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016; 14:240–247. PMID: 27433146.

18. Weng MT, Matsuoka K, Tung CC, et al. Incidence and risk factor analysis of thromboembolic events in Asian patients with inflammatory bowel disease, a multinational collaborative study. Inflamm Bowel Dis. 2018; (in press).